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Acute type A aortic dissection is a lethal condition requiring emergency surgery. It has diverse presentations, and
the diagnosis can be missed or delayed. Once diagnosed, decisions with regard to initial management, transfer,
appropriateness of surgery, timing of operation, and intervention for malperfusion complications are necessary.
The goals of surgery are to save life by prevention of pericardial tamponade or intra-pericardial aortic rupture, to
resect the primary entry tear, to correct or prevent any malperfusion and aortic valve regurgitation, and if possi-
ble to prevent late dissection-related complications in the proximal and downstream aorta. No randomized trials
of treatment or techniques have ever been performed, and novel therapies—particularly with regard to extent of
surgery—are being devised and implemented, but their role needs to be defined. Overall, except in highly spe-
cialized centers, surgical outcomes might be static, and there is abundant room for improvement. By highlight-
ing difficulties and controversies in diagnosis, patient selection, and surgical therapy, our over-arching goal
should be to enfranchise more patients for treatment and improve surgical outcomes. (J Am Coll Cardiol
2011;58:2455–74) © 2011 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.06.067Acute type A aortic dissection (ATAAD) is highly lethal
and might be increasing in incidence (1). Surgery is believed
to save and extend life, but despite apparent advances,
diagnosis is often delayed, evidence for improving outcomes
is modest (2), and optimal surgical management remains
unclear (3–8). Recent reviews (6,7,9–12) have directed
limited attention to the provision and performance of
surgery. This review specifically examines areas of uncer-
tainty and controversy in diagnosis, provision of care, and
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promoting investigation to detect and treat the condition
earlier and to improve treatment outcomes.
Anatomy and Incidence
By definition, ATAAD involves the ascending aorta (AscAo) and
includes types I and II of the DeBakey classification. The
DeBakey classification categorizes dissections as type I
(involving the AscAo with distal extension), type II affecting
the AscAo only, and type III delineating disease of the
descending aorta (DescAo) and beyond. Modifications of
these classifications—which describe patho-anatomical
variants—exist, but for practical purposes, the original
classifications by specifying AscAo involvement and hence
risk of intra-pericardial rupture define those cases requiring
surgery (Fig. 1).
Neither classification dictates the site of the originat-
ing entry tear. In ATAAD a primary intimal tear is
usually present within the AscAo, sometimes accompa-
nied by secondary, more distal tears (13). In others,
involvement of the AscAo is due to retrograde propaga-
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mary tear originating within the
arch or DescAo (14). On occa-
sion, no intimal tear is identifiable.
Other acute aortic syndromes, in-
tramural hematoma, and deep
penetrating ulcer might have sim-
ilar presentations (15). The esti-
mated total incidence of acute
(type A and B) dissection is 30 to
43/1 million of population (pmp)/
year (16,17). The ATAAD con-
stitutes 50% of all cases (6), and
DeBakey type I lesions predomi-
nate. In the absence of predispos-
ing conditions, ATAAD is more
common with increasing age. It
is not known whether the appar-
ent increase in incidence repre-
sents improved rates of diagnosis
or a real effect due to changing
population age and risk profiles
(Fig. 2) (1,18).
Are We Diagnosing and
Treating All Patients?
Acute type A aortic dissection
has a plethora of presentations
that generate diagnostic uncer-
tainty. Although chest pain is the
most commonly reported symp-
tom, it might be absent in 15% to
20% of cases (19). Clinical diag-
nostic suspicion is mandatory
(12,20), because individual signs,
symptoms, electrocardiogram
(ECG), and chest radiograph
changes lack both sensitivity and
specificity (5). Without clinical
suspicion, patients are not imme-
diately channeled into an appro-
priate imaging pathway. Most
diagnostic chest pain algorithms,
primarily designed to detect
cute coronary syndrome (ACS), do not prompt imaging
nless ATAAD is suspected and the application of triple
ule-out coronary angiographic computed tomography (CT)
s likely to be limited and again based on clinical suspicion
21–23). Therefore, ATAAD diagnosis is rarely immediate
nd might be missed, misdiagnosed, or substantially delayed
n up to 40% of cases (24–26), sometimes being only
stablished at autopsy (13,15,25).
The ECGs and cardiac troponin (CTn) estimations are
rimarily used to facilitate ACS diagnosis and do not
Abbreviations
and Acronyms
ARR  aortic root
replacement
AscAo  ascending aorta
(or aortic)
AscAoR  ascending aorta
(or aortic) repair
ATAAD  acute type A
aortic dissection
CAD  coronary artery
disease
CT  computed
tomography
CTn  cardiac troponin
DescAo  descending
aorta
ECG  electrocardiogram
FemA  femoral artery
(or arterial)
FET  frozen elephant
trunk
FL  false lumen
(or luminal)
HCA  hypothermic
circulatory arrest
IRAD  International
Registry of Aortic
Dissection
ODA  open distal
anastomosis
PFL  patent or persistent
false lumen
RAxA/ScA  right axillary
artery (arterial)/subclavian
artery (arterial)
TAR  total aortic arch
replacement
TEE  transesophageal
echocardiography
TL  true lumen (or
luminal)
VSRR  valve-sparing root
replacementiscriminate between ACS and dissection. The ACS-type iCG findings occur in 26% of patients with ATAAD
Online Table 1) (27) and, when present with CTn eleva-
ion, might lead to misdiagnosis and inappropriate therapy,
ncluding antiplatelet agents, heparin, and thrombolysis.
cute aortic syndromes have no reliable point-of-care bio-
arkers. Several have been investigated (28,29), but none
re sufficiently discriminant for general use. At present,
-dimer measurement might be the most useful (30–35). A
egative D-dimer assay is highly predictive that a patient
oes not have dissection, whereas a high level makes the
ifferential diagnosis of ATAAD or pulmonary embolism
ar more likely (Fig. 3) (35). Both diagnoses might require
onfirmatory cross-sectional imaging. If the number of
atients with ATAAD that can be successfully identified
nd treated is to be increased, much work is required to
iscover and validate existing and novel biomarkers.
Once suspected, definitive imaging comprising CT,
ransthoracic echocardiography and transesophageal echo-
ardiography (TEE) and magnetic resonance imaging are
equired for confirmation (6,7,36). The diagnostic accuracy
f these investigations has been reviewed elsewhere (5).
ultislice ECG-gated CT angiography is likely to improve
iagnostic precision (37).
TAAD Outcomes With and Without Surgery
any ATAAD patients die, either before antemortem
iagnosis or treatment, due to aortic rupture, tamponade,
alperfusion phenomena, and heart failure secondary to
ortic regurgitation or coronary malperfusion.
The untreated mortality of type A dissection has been
eported to be approximately 1% to 2%/h after symptom
nset, with up to 90% of patients succumbing within 30
ays (38–40). In some of the earliest reports, 24-h mortality
as 35%, and over one-half the patients had died within
8 h (41–44).
If diagnosed, surgical repair is possible (26) but remains
igh-risk, with both mortality and neurological complica-
ion rates of 15% to 30%, despite increased understanding of
he pathophysiology, improved anesthetic, myocardial and
erebral protection techniques, and advances in post-
perative care (39,45–48). No randomized studies of med-
cal versus surgical management have ever been performed,
ut on the available evidence, surgery converts a 90%
ortality risk to at least a 70% survival chance. This
agnitude of effect means that ATAAD is an accepted
ndication for surgery (4–7,39,46,49), and no more than 2
atients need to be treated to gain survival benefit. The
urvival advantage of surgery versus medical management
ontinues in the longer term (50,51) as survival curves
ontinue to diverge.
Despite a number of laudable individual center series, the
vidence that overall surgical outcomes are improving is
odest, and the mortality rates of 15% to 30% reported in
he last 2 decades of the 20th century might not be
mproving in the new millennium (2,46–48,52).
2457JACC Vol. 58, No. 24, 2011 Bonser et al.
December 6, 2011:2455–74 Acute Aortic DissectionAlthough the Stanford classification conveniently com-
partmentalizes AscAo involvement and treatment direction,
the DeBakey classification provides more prognostic infor-
mation. Perioperative, long-term, and aneurysm-free pa-
tient survival is greater in Type II than Type I dissection.
This relates to the propensity for distal malperfusion phe-
nomena and persistence of a distal false lumen (FL).
Patient selection for surgery: should all ATAAD patients
be operative candidates? Some ATAAD patients have
such advanced presentations, particularly due to malperfu-
sion phenomena, that surgical repair seems futile. The
pre-operative presentation of coma or in a collapsed state
with shock secondary to either pericardial tamponade or
coronary dissection and ischemia are consistent predictive
factors for postoperative mortality (39,53– 61). These and
other factors have been incorporated into predictive risk
models (56,57) on the basis of International Registry of
Aortic Dissection (IRAD) and individual center data
(Tables 1, 2, and 3) (46,62), which might aid the decision-
making of the attending surgeon (46). However, although
each complication might engender additional risk, this does
not preclude a superior outcome with surgery and rigid
Figure 1 Subtypes and Complications of Aortic Dissection
(A) Type A and (B) Type B aortic dissections. Type A encompass DeBakey I (asce
and Type B DeBakey III classifications. Reproduced, with permission, from Golledgtreatment exclusion criteria are inappropriate. Nevertheless,certain patients, moribund or comatose due to the lethal
consequences of established malperfusion, might be exces-
sively high-risk operative candidates, and selected medical
management, dictated by local center outcomes for such
cases, is justifiable.
ATAAD repair in octogenarians. In Western societies,
nearly one-fifth of the population are 65 years of age, and
this fraction is increasing. The ATAAD incidence increases
with age, and as with all emergency cardiovascular surgery,
age is an independent predictor of worse operative mortality
and morbidity and reduced longer-term survival
(38,39,47,55–59,61,63–68). Data from the IRAD registry
suggest that one-third of patients presenting with ATAAD
are over 70 years of age, with only 47.6% of patients older
than 80 years of age undergoing surgery. Surgical mortality
for this group approximates 40%, compared with 58% for
medically managed patients (69). In some series, surgery on
octogenarian ATAAD patients is associated with a 40% to
80% perioperative mortality (70,71). In contrast, survival
and hospital discharge rates of 41% have been reported in
some medically treated patients (39). Such reports and the
significant mortality and neurological event risk evident
aorta only and, therefore, less potential for malperfusion phenomena) and II
Eagle (12).nding
e andeven within younger patients has prompted a debate with
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(70,72–79). The data are conflicting. Some expert groups
have demonstrated excellent survival with few complications
(72,77,80–82) and maintained quality of life (83,84), out-
comes highly superior to those anticipated with medical
management (85,86). However, a proportion of surviving
patients might be significantly compromised and unable to
live independently (74). Data from the IRAD registry at
present show ATAAD repair in octogenarians remains
reasonable, provided the additive risk assessment of malp-
erfusion complications and pre-existent comorbidities are
considered and clinical judgment in light of local surgical
outcomes is applied.
Where should surgery be performed? The ATAAD sur-
gery, although conceptually simple, is actually practically
demanding. Difficulties arise in the handling of tissues
profoundly weakened by dissection; the judgments; and the
need to anticipate, identify, and react to any intra-operative
malperfusion. Most (approximately 75%) ATAAD patients
are diagnosed in peripheral hospitals (87) and transferred to
the nearest surgical center for treatment. Few such centers
Figure 2 Increasing Incidence of Aortic Aneurysm
and Dissection Over a 15-Year Period
Reproduced, with permission, from Olsson et al. (1).have established programs of aortic surgery, and fewer stillwill have comprehensive on-call arrangements for multi-
disciplinary aortic teams, including surgeons, anesthesiolo-
gists, and endovascular specialists. Thus, ATAAD patients
might undergo surgery by a team unfamiliar both with the
condition and the adjunctive techniques that are believed to
affect outcome (e.g., varied arterial cannulation techniques,
techniques of aortic valve reconstruction or aortic root
replacement [ARR], adjunctive cerebral protection tech-
niques, extended procedures and interventions for
malperfusion).
This unfamiliarity provides a cogent argument for cen-
tralizing dissection and thoracic aortic surgery management.
This would concentrate personnel, expertise, and systems,
allowing patients to benefit via the volume-outcome rela-
Figure 3 ROC to Demonstrate the Performance of D-Dimer
Analysis in the Diagnosis of Patients With Acute AD
The area under the curve on receiver-operator characteristics (ROC) curve anal-
ysis for patients with aortic dissection (AD) within 24 h of symptom onset ver-
sus all control subjects was 0.84 (95% confidence interval [CI]: 0.78 to 0.89)
and 0.81 (95% CI: 0.72 to 0. 90), 0.93 (95% CI: 0.87 to 0.98), 0.65 (95% CI:
0.36 to 0.93), and 0.82 (95% CI: 0.73 to 0.90) versus myocardial infarction
(MI), angina, pulmonary embolism (PE), and other uncertain diagnoses, respec-
tively. The greatest area under the ROC curve is for AD versus angina; lower
values are found for MI, and D-Dimer is unable to differentiate AD from PE but
could direct patients into an appropriate imaging algorithm. Reproduced, with
permission, from Suzuki et al. (35).
Preoperative Predictors of Mortality AssociatedWith Type A Disse ionTable 1 Preoperative Predictors of Mortality AssociatedWith Type A Dissection
Variable
Death Odds Ratio
(95% CI)
Age 70 yrs 1.98 (1.19–3.29)
History of aortic valve replacement 4.21 (not available)
Presentation with hypotension, shock or tamponade 3.23 (1.95–5.37)
Migrating chest pain 2.42 (1.32–4.45)
Pre-operative tamponade 2.65 (1.48–4.75)
Any pulse deficit 1.75 (1.06–2.88)
ECG infarction or new ischemia 1.76 (1.02–3.03)Adapted and reproduced, with permission, from Rampoldi et al. (57).
CI  confidence interval; ECG  electrocardiogram.
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December 6, 2011:2455–74 Acute Aortic Dissectiontionship consistently demonstrated in cardiovascular surgery
(88–90). However, although performance and quality met-
rics are in widespread use in other areas of cardiovascular
disease, none have as yet been established for thoracic aortic
surgery or ATAAD management (23). Where geography
and transport times allow, peripheral hospital presentation
and diagnosis provides an opportunity to have directed
transfer to specialist-designated centers (91,92). Such di-
rected transfer could improve outcomes significantly and
would be enhanced if biomarkers were identified that
allowed detection of patients with a high risk of dissection
at pre-hospital presentation.
When should surgery be performed? Because the un-
treated natural history is so lethal, the possibility of directed
transfer has to be reconciled against time to treatment. In 1934,
Shennan (93) reported that 40% of ATAAD patients die
immediately, 70% within 24 h, 94% within 1 week, and 100%
within 5 weeks. Similar attrition rates have been reported by
others (41,43,94–97) and are the justification for emergent
transfer policies to the nearest available center (7,9,12). Al-
though the need for emergency surgery is apparent, it should
be noted that the reported high mortality rates in early series
included patients who died abruptly at symptom onset (41) in
whom diagnosis was only made at postmortem. More recent
data suggest that the 30-day attrition rate for patients admitted
and diagnosed in life but not undergoing surgery is actually
lower and slower than first thought (39,57,98–100). The risk
of death seems to exponentially reduce as the first hours after
Intra-Operative Predictors of Mortality AssociatedWith Type A Diss ctionTable 2 Intra-Operative Predictors of Mortality AssociatedWith Type A Dissection
Variable
Death Odds Ratio
(95% CI)
Age 70 yrs 1.79 (1.02–3.15)
History of aortic valve replacement 5.93 (2.07–16.97)
Presentation with hypotension, shock, or tamponade 2.52 (1.40–4.54)
Migrating chest pain 2.02 (1.02–4.02)
Any pulse deficit 1.90 (1.10–3.29)
In operation
Hypotension or shock 3.81 (2.16–6.71)
RV dysfunction 4.90 (2.00–12.00)
Partial arch 0.52 (0.28–0.98)
CABG 2.54 (1.23–5.24)
Adapted and reproduced with permission from Tan et al. (62).
CABG  coronary artery bypass grafting; CI  confidence interval; RV  right ventricular.
Independent Pre-Operative Risk Factors for Mortality in Patients WTable 3 Independent Pre-Operative Risk Factors for Mortality i
Variable at Presentation % Incidence in Type A % Am
History of aortic valve replacement 4.4
Migrating chest pain 14.2
Presenting hypotension 17.6
Presenting shock/tamponade 24.7
Pre-operative cardiac tamponade 15.7
Pre-operative limb ischemia 9.7Modified and reproduced, with permission, from Trimarchi et al. (46).
CI  confidence interval.symptom onset pass. In diagnosed cases, time from initial
symptoms to hospital presentation approximates 1 to 2 h (87).
elayed admission adversely affects outcome (101). Once
dmitted, the time to diagnosis varies greatly (102); 50% of
atients have a time to diagnosis 6 h in Europe and 15 h
n the United States, with 75% of patients having diagnostic
imes 3 to 4 h (87). A time-dependent post-admission
ortality risk can be inferred from IRAD and other published
ata. A medically managed ATAAD patient has a 15% to 30%
ortality risk in the first 24 h of admission, a 10% to 20% risk
etween 24 and 48 h, and a similar risk between days 2 and 5
39,43,44,51). Between days 5 and 30, the risk of death reduces
o approximately 1%/day (Online Fig. 1) (51).
Diagnostic delay is increased by presentations that do not
voke clinical suspicion, including painless onset, dyspnea
econdary to heart failure or pleural effusion, CTn-
ositivity, ACS-type ECG, neurological presentations, limb
schemia, or abdominal pain (12,103,104). The time from
ymptom onset to commencement to surgery is even longer,
nd contrary to expectations, 20% to 50% of patients do not
ndergo surgery until 24 h or more after symptom onset
51,104,105). In some series, nearly one-half of all patients
ave a delay of more than 48 h between symptoms and
resentation to a tertiary center (104).
Because the risk of death between symptom onset and 48 h
s appreciable, emergency operation remains indicated in pa-
ients presenting during this period. Early presenting, appar-
ntly stable ATAAD patients have an ongoing mortality risk
n the interval between center admission and operation, and
his might constitute 5% of admitted cases (104). No report
uggests delay in the first 24 h after symptom onset is safe
ractice, and immediate emergency status should be accorded
o those rapidly diagnosed patients presenting early after
ymptom onset with hemodynamic compromise, shock, tam-
onade, myocardial ischemia, or heart failure secondary to
cute aortic valve regurgitation or neurological disturbance.
re-operative tamponade is an important risk factor for mor-
ality, and because presentation for the majority of cases occurs
utside specialist centers, a decision with regard to pericardio-
entesis for stabilization is necessary, but the appropriateness of
his is debated (106).
The optimal management of ATAAD patients arriving
t a center beyond 48 h of symptom onset who are pain-free
nd hemodynamically stable without evidence of malperfu-
cute Type A Aortic Dissectionients With Acute Type A Aortic Dissection
rvivors % Among Nonsurvivors Mortality Odds Ratio (95% CI)
7.4 3.12 (1.16–8.40)
20.5 2.77 (1.49–5.15)
30.4 1.95 (1.08–3.52)
40.7 2.69 (1.41–5.11)
27.6 2.22 (1.17–4.22)
15.8 2.10 (1.00–4.38)ith An Pat
ong Su
3.5
12.1
13.3
19.5
11.8
7.8
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Acute Aortic Dissection December 6, 2011:2455–74sion or pericardial effusion is unclear. Such patients are
likely to be older with more comorbid disease and are more
likely to present with evidence of heart failure and abrupt
chest pain and have arch involvement (104). Although a
continued attrition rate is recognized, there is perhaps
sufficient time to undertake additional investigations and
schedule surgery urgently but not emergently. This ap-
proach should be aborted by any evidence of recurrent pain
or instability. In a nonrandomized study, equivalent out-
comes were obtained when such patients were more fully
investigated before planned daytime urgent surgery, but the
impact of additional investigations on management is un-
clear, and selection bias is possible (104). Thus, at present,
ATAAD within 48 h of symptom onset is a surgical
emergency. Stable patients presenting to surgical centers
beyond this time might potentially be scheduled in a more
planned fashion.
Malperfusion
Malperfusion phenomena have an incidence of 16% to 33%
(100,107–110) and might result in myocardial, cerebral,
spinal, extremity, renal, and visceral ischemia. They are
most common in extensive DeBakey type I dissection
(12,111). Clinically apparent malperfusion of any type
increases mortality risk (107,109,111,112). Although dem-
onstration of radiological malperfusion might also be im-
portant, it is the ischemic consequences of malperfusion and
end-organ dysfunction that compromise survival (Fig. 4)
(100,111,113,114). Thus, although a patient might have
CT evidence of reduced true luminal (TL) innominate
artery flow, the prognostic relevance of this is primarily
determined (Online Table 2) by the presence of clinical
neurological ischemia.
The mechanism is variable; malperfusion might occur
due to fixed or dynamic flap occlusion of the aorta or branch
artery or secondary to compromised flow in the supplying
FL or TL due to thrombosis of the former and compression
of the latter (112). The TL can also be significantly
compressed by a higher pressure FL, due to large entry tear
and an absent or small exit tear. Intimal shearing with flap
occlusion or intussusception within the aorta or its branches
might also occur.
Coronary malperfusion. Approximately 10% to 15% of
cases display coronary malperfusion (115,116). Over one-
half of these are initially misdiagnosed as ACS and might
inappropriately receive antiplatelet or thrombolytic therapy.
An ACS-type ECG is associated with more complicated
dissections and independently predicts early mortality (27).
Right coronary artery involvement is more frequent, and any
coronary malperfusion adversely affects outcome (56,117–
119). The sinus of Valsalva pathology and dissection in-
volvement associated with coronary malperfusion increases
the likelihood that ARR will be necessary (45,116,120).
The incidence of coronary artery disease (CAD) in
ATAAD is generally believed to be low, although 1 studysuggested that 1 in 3 patients will have evidence of CAD
(121). Notwithstanding this, there is a consensus that
coronary angiography should not be performed in the
emergency setting (122–124), because yield is low, emer-
gency operative intervention might be delayed, and cathe-
terization could lead to aortic rupture or malperfusion
exacerbation. Currently, coronary ischemia in the emergent
Figure 4 Kaplan-Meier Survival Curves of Actuarial Survival
Kaplan-Meier survival curves of actuarial survival of patients with (A) any
malperfusion syndrome, (B) coronary malperfusion
syndrome, and (C) central nervous system malperfusion syndrome. Repro-
duced, with permission, from Geirsson et al. (120).patient, without known CAD, should be assumed to rep-
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a
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is reserved for stable patients with a clinical history of CAD
or intervention and perhaps those presenting 48 h after
symptom onset (104). Intra-operative angiography has been
suggested but is not yet in common use (125,126). An
alternative strategy would be the use of ECG-gated CT
angiography to assess for the presence of CAD.
The surgical technique required to deal with coronary
malperfusion depends upon its mechanism, which might be
embarrassment of the coronary ostium by a dynamic intimal
flap, dissection of the ostium with intimal shearing and even
intimal intussusception (117,120,127–129). Compromised
flow due to TL compression with an intact intima can be
dealt with by re-affixation of the dissected layers, even if
there is periostial dissection. Alternatively, coronary ostial
button re-implantation might be performed if root replace-
ment has been required. The classical Bentall procedure—in
which ostial re-implantation is performed without button
creation—is ill-advised, because the risk of anastomotic
disruption and pseudoaneurysm is increased. For more
extensive vessel dissection or intimal disruption, coronary
artery bypass grafting—performed in approximately 15% of
cases—is necessary, usually with autologous saphenous vein. The
hreshold for coronary artery bypass grafting should be low.
In the presence of coronary malperfusion, in-hospital
ortality doubles and some patients will die intra-
peratively from low cardiac output. Longer-term survival is
lso reduced with an overall 5-year survival of 22% (116).
owever, if hospital survival is achieved, conditional sur-
ival thereafter is nearly equivalent to those without coro-
ary malperfusion.
hemanagement of brainmalperfusion andparaplegia. Brain
malperfusion is usually due to TL flow embarrassment of a
supra-aortic artery by FL pressurization. Its management
remains a surgical dilemma. Patients with dense deficits or
coma have a poor post-operative prognosis, and intervention
in such cases might be considered futile (46,113,116,130).
However, recovery has been reported in isolated cases in
which rapid reperfusion is achieved (131–135). In contrast,
conscious patients with a transient or even persistent neu-
rological deficit pre-operatively have a similar operative and
longer-term survival as nondeficit patients, and over 50%
will fully regain neurological function (116,120). The tim-
ing of intervention is crucial; a shorter time between
symptom onset and surgical reperfusion improves outcome,
and if reperfusion is achieved in 5 h, this has a reasonable
prospect of limiting stroke progression (136,137). A precise
cutoff time above which recovery is unlikely is undefined. A
10-h threshold below which neurological conservation and
recovery might be higher has been suggested (116,138), but
reperfusion is no guarantee that stroke will be prevented
or that full independent rehabilitation will occur
(111,116,139). Because speed of reperfusion is so important,
early presenting ATAAD with brain malperfusion should
have direct transfer to the operating room. Cannulation and
reperfusion strategies might be critical in improving neuro-logical outcome, but it should be noted that high de novo
neurological complication rates of ATAAD repair remain a
significant risk (140).
Paraplegia due to malperfusion phenomenon might also
occur, but its etiologic mechanism is less clear, due to the
multi-source origin of cord perfusion. Shearing of multiple
intercostal arteries might abruptly interrupt anterior spinal
artery collaterals, and this might be exacerbated by any
embarrassment of vertebral artery flow, dynamic alterations
in aortic TL flow, or compromise of internal iliac perfusion.
Not all of these might be correctable by restoration of TL
flow, and in consequence, the prospects for recovery are less;
there are only a limited number of successful paraplegia
reversals (116,120). However, in the hope rather than
anticipation of neurological recovery, early presenting para-
plegia represents an indication for emergency intervention.
Extremity malperfusion. Limb malperfusion (most com-
monly lower limb) occurs in approximately 12% of ATAAD
patients. As the primary presentation, it is a cause of
diagnostic delay, particularly when unaccompanied by torso
pain. Although often accompanied by malperfusion phe-
nomena elsewhere, in isolation, limb malperfusion does not
affect survival outcome. A higher incidence of acute renal
failure post-operatively, presumably related to reperfusion
nephrotoxin release and contrast investigations, has been
noted (116). Standard surgical therapy with restitution of
orthograde TL flow successfully resolves limb malperfusion
in most cases, but some will require additional femoro-
femoral bypass or endovascular procedures, including inti-
mal flap fenestration or stent-graft placement if malperfu-
sion persists after the primary repair (141).
Visceral malperfusion. Of all such phenomena, visceral
malperfusion is the most lethal, heralding an extremely poor
prognosis, unless the malperfusion is corrected and nonvi-
able gut is excised (110). Advanced visceral malperfusion,
managed by initial ascending aortic surgical repair and
post-repair laparotomy, has a high mortality (100,142). This
mortality might reduce if malperfusion is first treated by
endovascular fenestration with or without branch vessel
stenting (100,113,143). However, delay in ascending aorta
repair (AscAoR) leads to a significant attrition rate, due to
aortic rupture (113,144). Patient survival is thus dependent
upon both the duration, extent, severity, and reversibility of
visceral ischemia and the ability to repair the AscAo.
Therefore, management is primarily an issue of diagnostic
timing. Surgical opinion is divided, with some advocating
initial percutaneous or extra-anatomic reperfusion (145) of
either clinically significant or radiologically identified malp-
erfusion followed by delayed AscAo repair and others
recommending immediate AscAo repair rapidly followed by
investigation and treatment of residual malperfusion. An-
other option, which requires hybrid operating theaters,
comprises near-contemporaneous percutaneous interven-
tions or antegrade stent deployment at the same sitting as
the proximal procedure (146–151), but whether angio-
graphic pursuit of subclinical malperfusion and endovascular
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unclear. Initial interventional angiography might subject the
patient to a risk of rupture and renal injury that might also
adversely affect survival (46,144). Very early presentation
might yet be best treated by early restitution of aortic TL
flow by primary AscAoR.
The prevailing view is that, in the absence of ongoing
severe visceral ischemia with gangrenous bowel and acidosis,
proximal repair should occur first. If there is concern with
regard to visceral perfusion on initial imaging, this can be
verified via a laparotomy extension of sternotomy. However,
when visceral ischemia is clinically apparent and advanced,
peripheral reperfusion and resection of ischemic intestine as
a preliminary course of action seems more likely to achieve
patient survival and prevent futile aortic reconstruction in
nonviable candidates (116). At present, there is insufficient
evidence to declare which strategy is optimal in which
patients, but again, the complexities of ATAAD manage-
ment is a prompt toward transfer to designated multi-
disciplinary units equipped with a full array of interven-
tional, hybrid, and surgical techniques (152).
Renal malperfusion responds well to primary aortic sur-
gery, but some cases will require additional interventional
procedures (116,120).
The Aims and Objectives of ATAAD Surgery
The primary aim is prevention of intra-pericardial rupture.
This is accomplished by AscAoR accompanied, where
possible, by excision of the proximal entry tear. Other
objectives include prevention or treatment of coronary ostial
dissection, correction of any aortic valve insufficiency, res-
toration of dominant TL flow in the distal aorta, correction
of distal malperfusion, and if possible, permanent oblitera-
tion of the FL in the distal aorta (12). Techniques used to
achieve these aims have not been subject to randomized
studies (4).
Historically, various methods of AscAoR have been
described, including inlay grafts, direct entry excision, and
end-to-end aortic anastomosis as well as sutureless, ringed
intra-luminal grafts (153–155). Most current approaches
replace the AscAo with a prosthetic graft (usually protein-
impregnated to prevent blood extrusion) and use sutured,
often buttress-reinforced anastomoses (156).
Technical aspects remain issues of debate (157–159)—
even in how anastomoses should be constructed (160,161).
Anastomoses must be hemostatically secure, a great chal-
lenge in ATAAD surgery. Various surgeon-specific tech-
niques—including no reinforcement, external buttressing,
bi-layer buttressing, or fabric insertion in the dissection
plane—have been advocated, but there are few comparative
data to guide practice (157,162).
The site of arterial cannulation for bypass. Acute type A
aortic dissection repair requires cardiopulmonary bypass
necessitating arterial cannulation (Online Table 3). The
femoral artery (FemA) has been used for decades, due to jease of access, size, and ability to achieve adequate flow
(163,164). However, FemA perfusion carries the potential
risk of differentially pressurizing the FL, generating malp-
erfusion (165–167). In autopsy series, the theoretical poten-
tial for brain malperfusion with FemA cannulation was
42%, whereas perfusion via the axillary artery limited this to
only 16% (13). However, the clinical incidence of malper-
fusion with FemA cannulation is low (168), provided
intra-operative monitoring enables rigorous real-time eval-
uation of brain perfusion, allowing intra-operative adjust-
ment of cannulation site (169). To monitor intra-operative
brain malperfusion, arterial pressure monitoring both prox-
imal and distal to the aortic arch is advised (129,170),
supplemented by forehead regional near infra-red spectro-
scopic monitoring of cortical regional mixed oxygen satura-
tion (171). No currently available device can survey perfusion
dequacy of the whole brain. Intra-operative time-points at
hich brain malperfusion is a particular hazard include the
nitiation of bypass, placement of an AscAo clamp, and
einstitution of bypass after aortic repair. To ensure TL
erfusion after distal reconstruction, to minimize retrograde
elivery of embolic material, and to minimize FL pressur-
zation, there is an overwhelming consensus that orthograde
orporeal perfusion via the aortic graft should be instituted
f FemA cannulation has previously been used. Femoral
annulation is ill-advised in the presence of distal aortic
therosclerotic disease, because it risks proximal atheroem-
olization (172,173). In the context of ATAAD, initial
emA cannulation remains reasonable, provided malperfu-
ion monitoring is applied and aortic imaging confirms an
bsence of atheroma. In cases when adequate bypass flow is
ot achievable with FemA return, a secondary cannulation
echnique becomes mandatory. A FemA cannulation is
ontraindicated in the presence of known or suspected
oarctation (e.g., ATAAD in Turner’s syndrome).
The use of the right axillary or subclavian artery (RAxA/
cA) has been advocated as an alternative (174–178).
urgical preparation is more time-consuming, but several
eports (179–183) suggest improved outcomes with RAxA/
cA cannulation in ATAAD and arch surgery, compared
ith historical controls (184). An RAxA/ScA cannulation,
owever, is not risk-free, and complications include brachial
lexus injury and de novo or propagation of dissection
149,185–191), and the need for intra-operative brain mon-
toring remains important. Although RAxA/ScA cannula-
ion reportedly might reduce stroke rate and mortality in
TAAD (180,192), published series have often compared
utcomes with a sicker, more emergent FemA patient
roup. If stroke protection is truly reduced, this might relate
o earlier perfusion of a compromised innominate artery,
aintenance of antegrade brain blood flow during any arrest
eriod, or the avoidance of retrograde flow in an atheroma-
ous aorta (193). In the absence of randomized or carefully
atched cohort studies, a uniform recommendation for the
rimary use of RAxA/ScA cannulation is not currently
ustified. In small series, combined RAxA/ScA and FemA
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encouraging outcomes (194). Carotid and innominate artery
cannulation to avoid malperfusion have also been used by
some authors (195–197,198), and occasionally unique per-
fusion solutions have been generated to combat intra-
operative malperfusion (199).
The importance of ensuring TL perfusion has led to the
usage of direct cannulation approaches, including passage of
a cannula into the AscAo via the left ventricular apex (200).
Advantages include speed, simplicity, adequacy of flow, and
apparent reliability of TL perfusion. However, trans-apical
cannulation carries the risk of ventricular injury, cannula
malposition via an intimal tear into the FL, and intra-
operative aortic regurgitation. Although a primary tech-
nique for some surgeons, it is an important secondary
cannulation site for others, if malperfusion is detected
during perfusion via another peripheral route.
Direct cannulation of the TL within the AscAo
(194,201–207) is a further alternative. It can be achieved in
2 ways. Firstly, after venous drainage exsanguination, the
AscAo can be partially transected, the TL can be identified,
and a cannula can be sited under direct vision (206). A
second method is to directly cannulate with ultrasound
imaging or CT inspection to identify the true lumen (208).
This method achieves outcomes equivalent to FemA can-
nulation, but debate over safety and efficacy continues
(192,209). Because the superiority of specific cannulation
techniques has not been established (164,192,193,210),
currently the cannulation site should be selected on the basis
of pathology, patient status, the presence of atheromatous
disease or malperfusion, and surgical familiarity with the
options available. For each case, the surgeon should be
familiar with several alternatives.
Aortic clamping during the conduct of proximal repair. It is
possible to clamp the distal AscAo while on bypass and
undertake the proximal part of the repair (116,208). Al-
though clamping could allow FL pressurization and malp-
erfusion, retrospective series have not identified this as a
significant risk (211–213), except possibly for neurological
morbidity (214,215). However, many experienced aortic
surgeons counsel against clamping, proceeding initially to
the open distal reconstruction followed by the proximal
surgery during the re-warming phase. Clamping during the
cooling phase might still be necessary in the presence of
ascending aortic rupture or to expedite treatment of coro-
nary malperfusion or aortic regurgitation with left ventric-
ular distension.
What procedure for the aortic valve and root? The
intra-operative management of the ATAAD aortic root
involves assessment of aortic valve competence, annular
diameter, morphology, dimension of the sinuses of Valsalva
and the sino-tubular junction, the coronary ostial position,
and the extent of proximal dissection propagation (155).
There is consensus that direct inspection should be sup-
ported by intra-operative TEE. New aortic regurgitation in
ATAAD usually occurs when the dissection involves theaortic root detaching the commissures from the aortic wall,
permitting cusp prolapse (216). Approximately 30% of
patients have an aortic diastolic murmur, and approximately
one-half have aortic regurgitation on investigation (216).
The surgical management of this is controversial (217,218).
Preservation of the native aortic valve has obvious advan-
tages. Because valve leaflet morphology is often normal,
valve competence can usually be restored by re-affixing the
commissures to the aortic wall (219,220) (Online Fig. 2)
with a nondissected commissure height as a reference. The
technique uses full-thickness suture fixation, but this might
be supplemented by glue fixation of apposed dissected layers
(49,221–223) or insertion of custom-sized and -shaped
fabric neomedia inserts (157,158,224). The method used is
surgeon-specific and comparative data are not available.
Glue fixation alone might not be secure, increasing the
risk of re-operation (223,225,226). Flap interference with
valve closure or central regurgitation due to prior aortic
dilation at the sino-tubular junction are additional causes
of regurgitation that might be amenable to valve-
conserving repair.
Despite satisfactory early outcomes of conservative valve
management (49,215,225,227,228), 20% to 25% of patients
might develop late root enlargement or progression of aortic
regurgitation, necessitating aortic valve replacement or
ARR (105,229,230). Risk factors include an aortic annulus
27 mm at initial surgery and above-moderate valve regur-
gitation (225,230). Therefore, some centers use a more
aggressive strategy with a low threshold for prosthetic
ARR (Online Fig. 3) (231,232). This strategy reduces the
risk of native valve failure but adds the risk of prosthetic
valves. An ARR could also increase risk in inexpert hands.
Thus, the role of aggressive ARR management of the aortic
valve versus conservative valve re-suspension is incompletely
defined.
Sinus-retaining, valve-conserving techniques are inappro-
priate in patients with pre-existing root pathology as in
Marfan’s syndrome or annulo-aortic ectasia (233). In such
cases, ARR with a composite prosthesis is recommended.
An alternative is a valve-sparing root replacement (VSRR)
procedure (227,234). Of the 2 types of VSRR, the re-
implantation technique might be superior in ATAAD
(23,227,234,235). However, VSRR requires longer proce-
dure durations and more surgical judgment and might be
the right operation at the wrong time.
When a competent noncalcified bicuspid aortic valve is
detected, the decision to conserve will depend upon patient
age, presence of annulo-aortic ectasia, and degree of de-
struction of the aortic root. If the valve is functionally
abnormal but sinus of Valsalva disease is absent, prophylac-
tic aortic valve replacement with retention of the remainder
of the aortic root is justified. Alternatively, reparative
bicuspid valve procedures are well-reported, but their appli-
cation should be judicious.
The routine use of intra-operative TEE to guide and
assess repair, monitor TL flow, and assess global and
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adjunct (36,236,237).
Surgical Management of the Distal Aorta
The significance of a patent false lumen. A DeBakey type I
ATAAD treated by proximal aortic surgery usually leaves
the patient with a persistent distal patent false lumen (PFL),
the importance of which has been noted for decades
(38,238–241). Ostensibly, a PFL diminishes prognosis
(38,102,222,242–247), being associated with an increased
risk of death (248,249), re-operation (248,250), and aneu-
rysmal enlargement (213,251–254). In some reports a PFL
is associated with a 20% and 25% reduced chance of actual
and event-free survival at 5 years (212,255), whereas in
others a much lower effect is observed (256). Uncertainty of
the effect size of PFL on longer-term outcome fuels a major
debate with regard to the need for more extensive repair.
The region at most risk of aneurysm formation is the distal
arch and proximal DescAo (213,248,257,258). Natural history
studies consistently demonstrate a heightened expansion rate in
the PFL aorta (213,259), but expansion might be slow, linear,
and limited (249). Nearly 50% of PFL aortas will experience
growth rates 1.0 mm/year, and notably dissection-related
distal aneurysms cause only a minority of late post-ATAAD
deaths (255). The number of patients requiring late elective
re-operation within 5 years in most series is 2% to 13%
(105,212,213,224,249,255,256,260) but higher in some
(261,262). Marfan’s patients are an exception; however, if these
are excluded relatively few patients develop late aneurysmal
enlargement of the aorta (255). Importantly, re-operations
might be performed with low mortality (249). However,
follow-up is often incomplete, and the potential for aorta-
related mortality might be higher than the re-operation rate
suggests (212). The re-operation rate after AscAoR or hemi-
arch replacement might not be appreciably higher than rates
reported after more extended arch replacement (263–265). The
factors that might pre-dispose to aneurysm are: pre-existing
aortic dilation (213,259); uncontrolled hypertension (259);
non-resection of an entry tear (102,110,246,259); the presence
of larger-dimension FL diameters (in some but not all reports)
(247,262) and area (262,266); and as seen in type B dissection
(267), partial FL thrombosis (268). In the presence of a PFL,
vigilant life-long surveillance with interval scanning is neces-
sary, preferably with magnetic resonance imaging. Pragmati-
cally, scans at 3 and 6 months and then annually seem
satisfactory with interval adjustment if accelerated enlargement
or, conversely, stability at normal dimensions are detected.
Repeat surgical review is advisable if a minor diameter dimen-
sion of 5.5 cm is reached or expansion rate exceeds 1 cm/year1
(23). Such patients might be candidates for consideration of
intervention (269).
Operative techniques and the residual PFL. CLOSED
VERSUS OPEN REPAIR. The most common site of the inti-
al tear is the proximal half of the AscAo (13). This might
llow a closed technique of AscAoR undertaken with the Pistal AscAo clamped throughout the procedure. The alter-
ative is an open distal anastomosis (ODA) technique,
hich demands clamp removal with an anastomosis being
erformed during a period of hypothermic circulatory arrest
HCA) often supplemented by adjunctive brain perfusion
echniques. The closed technique has certain advantages. It
s quicker, because it avoids the necessity of profound
ooling and prevents the introduction of additional air and
ebris into the aortic arch (270). It is particularly applicable
o the small number of ATAAD–DeBakey type II dissec-
ions limited to the AscAo proximal to any clamp position.
losed techniques do not have worse operative mortality
han open anastomoses (212,215,242,259,270–273) unless
he inclusion technique that does not use full thickness
uturing is used (274,275). In addition, long-term survival
utcome might be similar (Online Fig. 4) (212). However,
closed technique disregards secondary tears within the
ortic arch present in 20% to 30% of DeBakey type I
TAAD (13,14,276), and the friable dissected AscAo
ight be injured by the clamp instrument, generating
urther intimal tearing. A closed technique results in near-
niform PFL persistence in DeBakey I dissections
257,272). Because it facilitated more complete repair and
ypothetically reduced PFL risk, ODA became both pop-
lar (277) and the accepted surgical norm (14,278). An
DA allows a more accurate approximation of the dissected
ayers and a direct visual inspection for further arch tears
279). If a clamp has been applied during cooling, the
ragmented clamp site might be excised during ODA
econstruction, potentially limiting PFL rates. However,
lthough lower PFL rates are reported, they remain disap-
ointingly high (60% to 80% in DeBakey type I ATAAD)
49,212,253,254). Nevertheless, current consensus favors an
DA. It allows anastomotic reconstruction in a fully
isualized aorta and offers the opportunity to provide a
emostatically secure anastomosis, to extend the repair into
he hemi-arch or beyond, to attempt re-approximation of
he intimal flap, and to detect and treat additional arch tears.
GLUE FIXATIONOF THEDISTAL AORTA AND ANASTOMOTIC
TECHNIQUES. Despite the purported utility of surgical
lues (221–223,243,280) to secure adhesion between inti-
al flap and FL wall in the distal aorta, there is little
vidence that they reduce PFL rates beyond that achieved
y an adhesive-free ODA technique (49,257). Reduced
e-operation rates have been observed in some series but not
thers (215,224,272,274), and there is concern with regard
o adhesive safety (223,274,281–283). Over-exuberant glue
pplication in the distal aorta might extrude through sec-
ndary tears, causing branch vessel occlusion or emboliza-
ion, and many surgeons withhold its use in the distal aorta
284).
EXTENSION OF THE AORTIC REPLACEMENT INTO THE
ARCH. Because an ODA has little effect on PFL prevalence,
urgeons have attempted to increase repair extent to reduce
FL rates. When the ODA is advanced to replace the
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extended ODA or hemi-arch), surgical risk remains
unchanged (158,212,272,279,285), but the effect on PFL
rate is limited. More extensive repairs requiring total aortic
arch replacement (TAR) have reduced PFL incidence to nearly
25% in some but not all reports (105,258,260,263,264,286–
294), but this might be at the expense of increased early
mortality risk (295), particularly in elderly patients (84). Al-
hough some report improved longer-term outcomes (287),
thers have not observed any reduction in late re-operation
ates (261,292,296,297). It is unlikely that this more complex
pproach could be generalized to the whole cardiovascular
urgical community and registry data could continue to dem-
nstrate that TAR is associated with increased surgical risk
46). Modifications that might simplify TAR are reported, but
onger-term outcomes are not yet formally reported (265,294).
HYBRID EXTENDED REPLACEMENT PROCEDURES: BARE-
METAL STENTING AND SEPARATELY DEPLOYED COVERED
STENT-GRAFTS. One approach to reduce PFL and promote
dissection regression and aortic remodeling involves the de-
ployment of a bare-metal stent that compresses the true lumen
against the outer medial-adventitial wall, promoting FL
thrombosis, TL expansion, and medial healing by cicatrisation.
This could avoid TAR and does not affect epi-aortic artery
patency. Although a PFL in the aorta beyond the stent would
remain, the vulnerable distal arch and proximal DescAo
(262,266) might be protected. Preliminary reports using stain-
less steel balloon-dilatable stents (Fig. 5) suggested that FL
obliteration could be achieved in70% of patients (298–302),
but recent reports suggest little PFL rate effect and no FL size
reduction (303). Incomplete deployment might occur, and if
inaccurate, there might be a heightened risk of aortic rupture.
Whether future developments will improve outcomes must be
the subject of detailed cohort studies with contemporary
matched control subjects.
Figure 5 Computed Tomography to Demonstrate a Type A Aort
Computed tomography to demonstrate a type A aortic dissection with extension in
placement of an intra-operative stent-graft after ascending aorta repair. Note the rAn alternative approach combines hemi-arch with cov-
ered stent-graft of the upper DescAo. Depending on the
extent of proximal repair, this technique might leave the
middle section of the aortic arch untreated. Covered stent
grafts are deployed either retrogradely or via the open aortic
arch. Preliminary reports suggest a reduction in PFL and
possibly late aneurysm development (150,304,305).
Stent-prosthetic graft combinations: the frozen elephant
trunk technique. The elephant trunk procedure (306), in
which a length of prosthetic graft beyond the distal arch
anastomosis in TAR floats freely within the DescAo,
facilitates interval repair of distal aortic aneurysms (307–
309). A recent modification, with a covered endovascular
stent-graft attached to a vascular graft, allows fixation of the
stent graft within the DescAo with vascular graft recon-
struction of the arch (310). This frozen elephant trunk
(FET) technique has facilitated single-stage TAR and
DescAo replacement in complex aneurysms and has been
extended to ATAAD (Fig. 6) (151,311).
The FET technique has been demonstrated to promote
L thrombosis, reduce distal PFL rates and deal with
econdary tears in the arch and re-entry tears in the
roximal DescAo (149,150,311–317). Patent false lumen
ates of 10% versus 89% in non-FET patients are reported.
he stent graft might expand a compressed true lumen and
hereby ameliorate distal aortic malperfusion. However,
lthough FET and other more complex stent-graft combi-
ations might be found to decrease late aneurysm formation
149,318–320), the procedures require total or substantial
rch replacement, automatically extending cerebral protec-
ion time and the period of corporeal circulatory arrest. This
ight increase stroke and paraplegia risk (320,321,322).
ne certain indication for FET is ATAAD with DescAo
upture (323), and it might also have a particular role in
etrograde dissection (324,325), but beyond these, indica-
ions are uncertain and controversial (326–330). Because
section and Repair
aortic arch (left). The right-hand post-operative image demonstrates
ion of the false lumen. Reproduced, with permission, from Leobon et al. (299).ic Dis
to the
esolut
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series (211,225,244,250,254,317) and can be performed
with modest surgical risk, patient subgroups that definitively
derive long-term benefit that might justify perioperative risk
need to be identified. Currently, whether patients with risk
factors for accelerated life-threatening aneurysm develop-
ment have a lower overall hazard with FET techniques
versus the cumulative risks of more conservative surgery,
surveillance monitoring (with an anticipated attrition rate),
and late re-intervention is unknown. In 1 series, FET-
treated patients had better medium-term survival than a
conventionally treated but higher-risk control group (291).
Sun et al. (331) have reported low operative mortality in
patients with ATAAD undergoing ascending repair with
TAR and ET. Distal FL obliteration in this group was
significantly reduced, compared with those undergoing
conventional repair (94.2% vs. 14.5%, respectively); this has
not as yet translated into a long-term survival benefit for the
more extensive procedure, compared with conventional
repair in the setting of ATAAD.
Thus, despite the impressive aortic remodeling data in
Figure 6 Hybrid Frozen Elephant Trunk Technique for Managem
Computed tomography scans at (A) 10 days, (B, D) 6 months, and (C) 12 month
in the descending aorta. In D, the false lumen is seen to refill in the distal descendownstream segments, such extensive procedures remainan unproven alternative to conventional ATAAD repair.
Additionally, any increase in surgical complexity and
extent must recognize their adverse relationship with
patient outcome.
Cerebral protection and monitoring during ATAAD
repair. A full review of intra-operative brain protection in
ATAAD is beyond the scope of this review. There is no
randomized trial evidence in ATAAD and only a small
amount in elective arch surgery (23). However, clinical
consensus has been reached in some areas. Because an ODA
is considered optimal practice, a period of HCA is neces-
sary. Even profound HCA provides only limited periods of
brain safety (approximately 20 min) (332), sufficient only to
perform a simple ODA. The HCA is insufficient for more
extensive reconstruction, and adjunctive brain protection
techniques are necessary. Retrograde brain perfusion via the
superior vena cava as an adjunct to deep hypothermia may
not be used, but the majority of arch procedures are now
undertaken with antegrade brain perfusion (333). The
delivery of antegrade perfusion may be via various routes
(334,335). Questions remain with regard to the ideal route,
f the Descending Aorta
onstrating continued thrombosis and exclusion of the false lumen
orta. Reproduced, with permission, from Jakob et al. (149).ent o
s dem
ding athe optimal perfusate composition, and the temperature of
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now recognized that corporeal arrest temperature is highly
relevant to spinal cord protection (336,337). In the context
of ATAAD, corporeal and cerebral protection techniques
and intra-operative monitoring to detect malperfusion are
essential components of the surgical strategy in striving for
a satisfactory complication-free patient outcome (23).
Summary
Acute type A aortic dissection requires rapid diagnosis
and treatment, if associated mortality is to be reduced.
Although imaging-based diagnostic accuracy is excellent,
the ultimate acquisition of the diagnosis is commonly
delayed. Referral and transfer for operation incurs further
delay, and surgery is commonly provided in nonspecialist
units. Patient selection for medical treatment should be
based upon a comprehensive appreciation of risk factors,
including comorbidities and dissection-related complica-
tions and not on a single factor such as age alone.
Malperfusion phenomena are common, invoke diagnostic
delay, and compromise survival. In most cases, reperfusion
as soon as possible after symptom onset achieves superior
outcomes. In an effort to treat more patients and improve
outcomes, we advocate: 1) research into pre-hospital diagnostic
recognition; and 2) establishment of designated specialist units
to facilitate all management.
Within surgical therapy, there are a host of controversial
issues that require resolution if outcomes are to be im-
proved. The evidence to determine best surgical manage-
ment is unlikely to be drawn from individual center studies
reporting surgeon-specific techniques in limited numbers,
comparative retrospective reports with historical controls, or
prospective reports in which more novel therapies are
directed toward more stable patients with consequent ap-
parent advantages. Randomized controlled trials of surgical
technique seem extraordinarily difficult for several reasons.
These include the difficulty in obtaining informed consent
in an emergency situation, the heterogeneity of the patient
population and pathology, and funding in the absence of
novel pharmacological agents. We believe that the most
efficacious way to address these many controversies is by the
accrual of registry data. Such registries should be large and
multinational, accruing very detailed perioperative data with
standardized reporting definitions. The detail is required to
clearly define the patient, clinical status, pathology, patho-
logical anatomy, and surgical findings and details of the
anesthetic, monitoring, and surgical techniques. Imaging,
both at diagnosis and follow-up, should be subjected to core
laboratory review and reporting, and outcome data should
be assessed independently. In this way, we will, in due
course, be able provide the evidence that informs surgical
practice and optimizes the management of this highly
dangerous condition.Reprint requests and correspondence: Prof. Robert S. Bonser,
Department of Cardiothoracic Surgery, University Hospitals Bir-
mingham National Health Service Foundation Trust, Edgbaston,
Birmingham B15 2TH, United Kingdom. E-mail: robert.
bonser@uhb.nhs.uk.
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